Call us Today! 201-728-8809 | | Contact | About |
   


Barcode Five Rights System

Use Barcode to prevent medication errors

ADERS ® is a barcode point of care, (BPOC), solution

Practical Compliance Solutions, Corp. helps care facilities reduce risk at the patient's bedside. Our five rights barcode solution is the easiest to implement. Our barcode point of care system can help prevent medication errors in hospitals, long term care facilities, and assisted living communities.

ADERS ® is our barcode solution for the healthcare industry. It helps eliminate medication errors by allowing caregivers to scan NDC barcodes at the patient's bedside, verifying right patient, right drug, right time, right dose, and right route of administration. For more information click the products menu or send us a web request from our Contact menu. Ask for a DEMO CD. It is the full product that is licensed for an evaluation period.

We are offering a 30 day no-obligation free trial of the ADERS ® software. Care facilities can easily determine if ADERS ® is right for them by using the software as a pilot for a single unit or ward. Click here to download a Microsoft Project plan showing how you can implement a five rights point of care barcode pilot in less than a week. If you Don't own MS Project 2003, then here is a PDF copy just to see.... Download Adobe PDF Data Sheet

View a PowerPoint Presentation of ADERS ®.

Get The Latest Patient Safety and Drug Safety Updates from the FDA

Food and Drug Administration--Press Releases

FDA clears first neonatal magnetic resonance imaging device
Thu, 20 Jul 2017 13:44:00 -0400

Today, the U.S. Food and Drug Administration cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging in neonatal intensive care units (NICU).

Statement from FDA Commissioner Scott Gottlieb, M.D., on the Funding Awards to States for FDA Food Safety Modernization Act (FSMA) Produce Safety Implementation
Wed, 19 Jul 2017 09:46:00 -0400

More than 3,000 Americans are estimated to die each year from foodborne illnesses and many more are hospitalized and sickened. Yet most of these illnesses and deaths are preventable. While the U.S. has one of the safest food supplies in the world, Congress entrusted the FDA with new authorities and resources – as part of the FDA Food Safety Modernization Act (FSMA) – to update and strengthen the FDA’s risk-based approach to the oversight of food safety.

FDA approves Vosevi for Hepatitis C
Tue, 18 Jul 2017 14:23:00 -0400

The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.

FDA approves new treatment to reduce the risk of breast cancer returning
Mon, 17 Jul 2017 16:42:00 -0400

The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer. For patients with this type of cancer, Nerlynx is the first extended adjuvant therapy, a form of therapy that is taken after an initial treatment to further lower the risk of the cancer coming back. Nerlynx is indicated for adult patients who have been previously treated with a regimen that includes the drug trastuzumab.

Statement from FDA Commissioner Scott Gottlieb, M.D., on National Academies of Sciences, Engineering, and Medicine report on pain management and prescription opioid abuse
Thu, 13 Jul 2017 13:24:00 -0400

In March 2016, the FDA asked the National Academies of Sciences, Engineering, and Medicine (NASEM) to outline the state of the science regarding prescription opioid abuse and misuse, as well as the evolving role that opioids play in pain management. We greatly appreciate all the work done by NASEM over the past year to produce the comprehensive report released today, which includes recommendations for the FDA and others on this important issue.

Statement from Alberto Gutierrez, Ph.D., Director, Office of In Vitro Diagnostics and Radiological Health, FDA’s Center for Devices and Radiological Health on the status of FDA’s investigation into inaccurate results from certain lead tests
Thu, 13 Jul 2017 10:30:00 -0400

On May 17, the U.S. Food and Drug Administration warned Americans that Magellan Diagnostics’ LeadCare test systems performed on blood drawn from the vein (venous) may provide inaccurate results.

FDA approves new treatment for sickle cell disease
Fri, 07 Jul 2017 11:16:00 -0400

The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder.

Federal judge enters consent decree against Alabama compounder Medistat
Thu, 06 Jul 2017 10:19:00 -0400

U.S. District Judge William H. Steele entered a consent decree of permanent injunction yesterday between the United States and Medistat RX LLC of Foley, Alabama, the company’s co-owners, Mark D. Acker and Timothy L. Fickling, and quality manager and pharmacist-in-charge V. Elaine Waller.

FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy
Mon, 03 Jul 2017 13:17:00 -0400

Today, the U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy. This is the first cooling cap cleared by the agency for use in cancer patients with solid tumors.

Federal judge orders New York smoked fish company to stop sales due to food safety violations
Fri, 30 Jun 2017 14:03:00 -0400

A New York smoked fish company has been ordered by a federal court to stop selling its products, which were produced in a facility that was contaminated with Listeria monocytogenes (L. mono), until it can comply with food safety regulations.

FDA allows marketing of test to aid in the detection of certain leukemias and lymphomas
Thu, 29 Jun 2017 16:44:00 -0400

The U.S. Food and Drug Administration today allowed marketing of ClearLLab Reagents (T1, T2, B1, B2, M), the first agency authorized test for use with flow cytometry to aid in the detection of several leukemias and lymphomas, including chronic leukemia, acute leukemia, non-Hodgkin lymphoma, myeloma, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN).

FDA unveils plan to eliminate orphan designation backlog
Thu, 29 Jun 2017 09:38:00 -0400

Today, the U.S. Food and Drug Administration unveiled a strategic plan to eliminate the agency’s existing orphan designation request backlog and ensure continued timely response to all new requests for designation with firm deadlines. The agency’s Orphan Drug Modernization Plan comes a week after FDA Commissioner Scott Gottlieb committed to eliminating the backlog within 90 days and responding to all new requests for designation within 90 days of receipt during his testimony before a Senate subcommittee.

FDA Tackles Drug Competition to Improve Patient Access
Tue, 27 Jun 2017 09:57:00 -0400

Today, the U.S. Food and Drug Administration is taking two new, important steps to increase competition in the market for prescription drugs and facilitate entry of lower-cost alternatives. The agency published a list of off-patent, off-exclusivity branded drugs without approved generics, and also implemented, for the first time, a new policy to expedite the review of generic drug applications where competition is limited.

Statement from FDA Commissioner Scott Gottlieb, M.D., on the importance of the Drug Quality and Security Act and overseeing the safety of compounded drugs
Mon, 26 Jun 2017 20:06:00 -0400

In late 2012, the United States faced the most serious outbreak associated with contaminated compounded drugs in recent history, involving hundreds of people, in many states, who developed fungal infections related to a compounded product. It was an incident that resulted in dozens of deaths.

FDA approves first subcutaneous C1 Esterase Inhibitor to treat rare genetic disease
Thu, 22 Jun 2017 17:15:00 -0400

The U.S. Food and Drug Administration today approved Haegarda, the first C1 Esterase Inhibitor (Human) for subcutaneous (under the skin) administration to prevent Hereditary Angioedema (HAE) attacks in adolescent and adult patients. The subcutaneous route of administration allows for easier at-home self-injection by the patient or caregiver, once proper training is received.

U.S. Marshals seize adulterated food from a Minnesota warehouse
Tue, 20 Jun 2017 13:24:00 -0400

The U.S. Food and Drug Administration announced that on June 15, the U.S. Marshals Service seized food products held at Professional Warehouse and Distribution, Inc., in St. Paul, Minnesota. The food products seized are worth approximately $73,000 and include, among other things, barley flour, spices, pasta, dried beans, tea and cookies.

Statement from FDA Commissioner Scott Gottlieb, M.D., on the 2016 National Youth Tobacco Survey results
Thu, 15 Jun 2017 13:49:00 -0400

While the latest numbers from the 2016 National Youth Tobacco Survey are encouraging, it is critical that we work to ensure this downward trend continues over the long term across all tobacco products. Every day in the U.S., more than 2,500 youth under the age of 18 smoke their first cigarette and more than 400 youth become daily cigarette smokers. It is also clear from these most recent numbers that youth are continuing to experiment with, or becoming regular users of, a wide range of other tobacco products.

Sonar Products ordered to cease operations, Stratus Pharmaceuticals ordered to cease distributing unapproved drugs
Thu, 15 Jun 2017 12:33:00 -0400

Today, U.S. District Judge Kathleen M. Williams for the Southern District of Florida entered a consent decree of permanent injunction between the United States and Stratus Pharmaceuticals Inc. of Miami, Florida, Sonar Products Inc. of Carlstadt, New Jersey and two of the companies’ officers, Alberto Hoyo and Juan Carlos Billoch.

Statement from FDA Commissioner Scott Gottlieb, M.D. – FDA is taking new steps to help assess opioid drugs with abuse-deterrent properties
Tue, 13 Jun 2017 09:03:00 -0400

Last month, I asked my colleagues at the FDA to identify what additional and more forceful steps the FDA can take, on top of the vigorous work the agency is already doing, to address the crisis of opioid addiction. Everyone at the FDA is committed to focusing on all aspects of the epidemic. The new policy steps that we announced included the formation of a steering committee to examine additional regulatory and policy actions that we can take to combat this crisis. This steering committee will place particular emphasis on evaluating efforts we can take to reduce the number of new cases of addiction.

FDA requests removal of Opana ER for risks related to abuse
Thu, 08 Jun 2017 16:15:00 -0400

Today, the U.S. Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market. After careful consideration, the agency is seeking removal based on its concern that the benefits of the drug may no longer outweigh its risks. This is the first time the agency has taken steps to remove a currently marketed opioid pain medication from sale due to the public health consequences of abuse.

Food and Drug Administration--Recalls/Safety Alerts

The Idaho Foodbank Recalls Coconut Beverage, Broccoli Cheddar Soup, Eggs, and Cheese Product Because Of Possible Health Risk
Fri, 21 Jul 2017 19:47:00 -0400

The Idaho Foodbank is recalling approximately 27,000 pounds of Coconut Beverage, Broccoli Cheddar Soup, Eggs, and Cheese Product. These products are being recalled because they were not continuously maintained or stored at the required temperature due to a malfunction in the cooler. This could result in contamination by spoilage organisms or pathogens, which could lead to life-threatening illness if consumed.

Bhu Foods Voluntarily Recalls Protein Bars for Possible Health Risk
Fri, 21 Jul 2017 19:37:00 -0400

Hudson Valley Foods, Inc. of Highland, NY has advised Bhu Foods of San Diego, CA that organic sunflower seeds sold to the company have been recalled. As a result of a recall of sunflower seeds from Hudson Valley Foods, Inc.,Bhu Foods’ supplier of organic sunflower seeds, advised Bhu Foods that ingredients sold to the company have the potential to be contaminated with Listeria monocytogenes.

Ultra Shop Supplement Issues Voluntary Nationwide Recall of Super Panther 7K Due to Presence of Undeclared Sildenafil and Tadalafil
Fri, 21 Jul 2017 15:40:00 -0400

Charlotte, NC, Ultra Shop Supplement is voluntarily recalling Super Panther 7K capsules, [1 count blister card Lot#: RO846356 and 6 count bottle Lot RO246852 within expiry], distributed by SX Power Co., Brooklyn, NY, to the consumer level. FDA analysis found samples of Super Panther 7K to be tainted with undeclared sildenafil and tadalafil, active ingredients in two FDA-approved prescription drug products, also known as phosphodiesterate 5-inhibitors (PDE-5), used to treat erectile dysfunction (ED).

Garden of Light Inc. Recalls Woodstock Organic Matcha Vanilla Oats Because of Possible Health Risk
Tue, 18 Jul 2017 11:37:00 -0400

Garden of Light, Inc. dba Gluten Free Solutions of East Hartford, CT, is voluntarily recalling the Woodstock Organic Matcha Vanilla Oats, 1.8 oz. which is manufactured by Garden of Light for Blue Marble Brands. The product has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women. The recalled item, Woodstock Organic Matcha Vanilla Oats, was distributed nationwide in retail stores.

Bestherbs Coffee LLC Issues Voluntary Nationwide Recall of New Kopi Jantan Tradisional Natural Herbs Coffee due to the Presence of Undeclared Active Pharmaceutical Ingredients and Undeclared Milk
Mon, 17 Jul 2017 14:55:00 -0400

Grand Priarie, TX, Bestherbs Coffee LLC is voluntarily recalling all lots of New of Kopi Jantan Tradisional Natural Herbs Coffee, 13 grams to the consumer level. FDA laboratory analysis confirmed the presence of desmethyl carbodenafil. Desmethyl carbodenafil is structurally similar to sildenafil, the active ingredient in Viagra, an FDA-approved prescription drug for erectile dysfunction (ED). New of Kopi Jantan Tradisional Natural Herbs Coffee also contains undeclared milk.

Texas Legend Foods Issues Allergy Alert on Undeclared Cheese, Milk & Egg in "Silver Star Chipotle Dip"
Fri, 14 Jul 2017 16:59:00 -0400

Texas Legend Foods of Austin, TX, is recalling its 16 ounce jars of Silver Star Chipotle Queso Dip because they contain undeclared cheese, milk and eggs. People who have allergies to cheese, milk and eggs run the risk of a serious or life-threatening allergic reaction if they consume this product.

Sunneen Health Foods Issues Recall of Parfait Due to Undeclared Allergens
Wed, 12 Jul 2017 10:42:00 -0400

Sunneen Health Foods is voluntarily recalling mislabeled Whole Foods Market PB&J parfaits sold at five Whole Foods Market stores in New York and New Jersey because the products contained soy and tree nut (almond and coconut) allergens that were not listed on the product label. People who have an allergy or severe sensitivity to soy or tree nuts run the risk of serious or life-threatening allergic reaction if they consume these products.

Andropharm Issues Voluntary Nationwide Recall of Sten Z and M1 Alpha Due to Labeling that it Contains Derivatives of Anabolic Steroids
Tue, 11 Jul 2017 17:45:00 -0400

lorida- Andropharm is voluntarily recalling all lots of Sten Z and M1 Alpha capsules to the consumer level because these products contain derivatives of anabolic steroids rendering them unapproved drugs for which safety and efficacy have not been established and therefore subject to recall.

Biohealth Nutrition Announces the Recall of Precision Blend Cookies and Cream Product for Undeclared Allergen
Mon, 10 Jul 2017 19:15:00 -0400

Biohealth Nutrition of San Dimas, CA is recalling Precision Blend Cookies & Cream because product labels failed to declare the food allergen, wheat. People who have an allergy or severe sensitivity to wheat run the risk of a life threatening allergic reaction, anaphylaxis, that requires immediate medical attention should they consume products containing allergens.

Coborn's, Inc. Issues Recall of Incorrectly Labeled Gluten Free Chocolate Chip Bars Due To Undeclared Milk
Mon, 10 Jul 2017 17:41:00 -0400

Coborn's, Inc. of St. Cloud, Minn. is recalling packages of its Gluten Free Chocolate Chip Bars, some of which were incorrectly labeled as Gluten Free Fudge Brownies. The Gluten Free Fudge Brownie label does not indicate the product contains milk, however the Gluten Free Chocolate Chip Bars that are incorrectly labeled as Gluten Free Fudge Brownies do contain milk.

Oscor Inc. Issues Nationwide Recall of ATAR Extension Cables
Thu, 06 Jul 2017 16:27:00 -0400

During the use of some ATAR extension cables, the cable was separating from the connector at the proximal end. The analysis of the returned devices revealed a change in the manufacturing sequence attributed to the connector and wire separation, causing a fracture of the conductor cable from extensive use.

Novo Nordisk Recalls Cartridge Holders In Certain Novopen Echo® Insulin Delivery Devices Due to Potential Health Risks
Thu, 06 Jul 2017 14:10:00 -0400

Novo Nordisk is initiating a recall of insulin cartridge holders used in a small number of NovoPen Echo® batches because they may crack or break if exposed to certain chemicals, like certain cleaning agents. NovoPen Echo® is used for insulin treatment by people with diabetes. Using a device with a cracked/broken cartridge holder may result in the device delivering a reduced dose of insulin which could potentially lead to high blood sugar. Novo Nordisk believes the risk of experiencing high blood sugar when using a device with an affected cartridge holder is low.

Voluntary Recall of CLIF BUILDER'S Bar Chocolate Mint Flavor, CLIF Kid Zbar Protein Chocolate Mint and CLIF Kid Zbar Protein Chocolate Chip Flavors
Wed, 05 Jul 2017 18:52:00 -0400

Clif Bar & Company is initiating a voluntary recall of CLIF® BUILDER'S® Bar Chocolate Mint flavor, and CLIF Kid Zbar® Protein Chocolate Mint and CLIF Kid Zbar® Protein Chocolate Chip flavors due to possible presence of undeclared peanuts and some tree nuts, including almonds, Brazil nuts, cashews, hazelnuts, macadamia nuts, pecans, walnuts and coconuts. Clif Bar & Company is taking this precautionary safety step for people who are allergic to peanuts and these listed tree nuts. People with an allergy to peanuts and these specific tree nuts run the risk of a serious or life-threatening allergic reaction.

Hardcore Formulations Issues Voluntary Nationwide Recall of Ultra-Sten and D-Zine Capsules Due to Labeling that it Contains Anabolic Steroids
Wed, 05 Jul 2017 17:41:00 -0400

Hardcore Formulations is voluntarily recalling all lots and expiration dates of Ultra-Sten and D-Zine capsules to the consumer level. These products are labeled to contain methylstenbolone (Ultra-Sten) and dymethazine (D-Zine), which are considered to be derivatives of anabolic steroids. The presence of these anabolic steroids in Ultra-Sten and D-Zine render them unapproved drugs for which safety and efficacy have not been established and therefore subject to recall.

Raja Foods Issues Allergy Alert on Undeclared Milk In "Anarkali Peshawari Naan Bread. Upc 0-51179-99605-2. Manufactured July 1st, 2015 Thru July 1st, 2017"
Wed, 05 Jul 2017 12:57:00 -0400

Raja Foods LLC of Skokie, Il is recalling its 15 ounce package of "ANARKALI PESHAWARI NAAN" because they may contain undeclared MILK. People who have allergies to MILK run the risk of serious or life-threatening allergic reaction if they consume these products.

Dierbergs Markets Issues Allergy Alert on Undeclared Fish and Milk in Product
Fri, 30 Jun 2017 17:29:00 -0400

St Louis-based Dierbergs is recalling various Deli Products with multiple use by dates in all retail stores because undeclared fish (anchovy) in a Caesar dressing and undeclared milk in 2 Santa Fe wraps. People who have allergies to fish and dairy run the risk of serious or life-threatening allergic reaction if they consume these products.

PharMEDium Services Issues Voluntary Nationwide Recall of Specific Lots of Potassium Phosphate and Succinylcholine Chloride Due to a Lack of Sterility Assurance
Tue, 27 Jun 2017 15:53:00 -0400

PharMEDium Services is conducting a limited, voluntary recall due to Hospira Inc.’s (“Hospira”) June 15, 2017 recall announcement that microbial growth was detected during a routine simulation of the manufacturing process and therefore there was a lack of sterility assurance. The products being recalled by PharMEDium Services were compounded using certain Hospira products.

Global Lamsheng Kee Inc. Issues Allergy Alert on Undeclared Egg in Frozen Fish Tofu, Frozen Fried Fish Ball and Frozen White Fish Ball
Tue, 27 Jun 2017 10:41:00 -0400

Global Lamsheng Kee Inc., Brooklyn, NY is recalling Frozen Fish Tofu, Frozen Fried Fish Ball and Frozen White Fish Ball because they may contain undeclared egg. People who have allergies to egg run the risk of serious or life-threatening allergic reaction if they consume these products.

Publix Recalls Publix Tropical Medley Mix Due to Possible Contamination with Listeria monocytogenes
Mon, 26 Jun 2017 12:42:00 -0400

Publix Super Markets is issuing a voluntary recall for Publix Tropical Medley Mix because it may be adulterated with Listeria monocytogenes. Publix received notification of the potential contamination from our supplier of dried apricot, The 5.7oz clear plastic containers of the mix were sold from Publix retail produce departments in Florida, Georgia, South Carolina, Alabama, Tennessee and North Carolina with a UPC of 41415088586. All use by dates are being recalled.

ADM Animal Nutrition Recalls Rough-N-Ready Cattle Feed A specific lot of product contains elevated levels of monensin, could harm cattle
Fri, 23 Jun 2017 19:31:00 -0400

ADM Animal Nutrition, a division of Archer Daniels Midland Company (NYSE: ADM), is recalling 50-pound bags of Rough-N-Ready 14 BT cattle feed, product number 54787BHB24, because the product contains elevated levels of monensin beyond the recommended dosage, which could be harmful to cattle. At elevated levels, monensin can be toxic to cattle and can cause colic-like symptoms, hypokalemia, myoglobinuria, chronic cardiovascular issues, and possible death.

What's New: Drugs RSS Feed

Medication Guides
Fri, 21 Jul 2017 10:32:00 -0400

Updated list of medication guides.

Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505A and 505B of the Federal Food, Drug, and Cosmetic Act, as amended by the FDA Safety and Innovation Act of 2012 (FDASIA)
Thu, 20 Jul 2017 18:16:00 -0400



Drugs@FDA Data Files
Thu, 20 Jul 2017 15:44:00 -0400

Data files updated through July 20, 2017.

Drugs@FDA Download File (new structure)
Thu, 20 Jul 2017 15:41:00 -0400

Data files updated through July 20, 2017.

Additions/Deletions for Prescription and OTC Drug Product Lists
Fri, 14 Jul 2017 14:24:00 -0400

The list has been updated through June 2017.

Orange Book Zip File
Fri, 14 Jul 2017 14:20:00 -0400

May 2017 Orange Book data files, ZIP format.

Pediatric Exclusivity Statistics
Mon, 10 Jul 2017 14:00:00 -0400

Updated list.

Written Requests Issued
Mon, 10 Jul 2017 13:51:00 -0400

Updated list of approved active moieties to which FDA has issued a Written Request for pediatric studies

Truthful Prescription Drug Advertising and Promotion
Mon, 10 Jul 2017 11:18:00 -0400



Microbiological Data for Systemic Antibacterial Drug Products — Development, Analysis, and Presentation
Mon, 10 Jul 2017 11:14:00 -0400

Clinical / Antimicrobial

Presenting Risk Information in Prescription Drug and Medical Device Promotion
Wed, 05 Jul 2017 12:48:00 -0400

Advertising

Inactive Ingredients Database Download
Mon, 03 Jul 2017 09:06:00 -0400

Data updated through July 2017

Potential Signals of Serious Risks/New Safety Information Identified from the FDA Adverse Event Reporting System (FAERS)
Mon, 03 Jul 2017 08:01:00 -0400

Updated Quarterly Reports

Clinical Investigator Inspection List (CLIIL)
Fri, 30 Jun 2017 11:45:00 -0400

The Clinical Investigator Inspection List contains names, addresses, and other pertinent information gathered from inspections of clinical investigators who have performed studies with investigational new drugs.

BMIS Zip Download File
Fri, 30 Jun 2017 11:39:00 -0400

File updated through 6/19/2017.

Newly Added Guidance Documents
Thu, 29 Jun 2017 14:16:00 -0400



Postmarket Drug and Biologic Safety Evaluations
Thu, 29 Jun 2017 10:03:00 -0400

Updated

What's New: Vaccines, Blood & Biologics RSS Feed

Clinical Investigator Status (Biologics)
Tue, 18 Jul 2017 07:38:00 -0400

Clinical Investigator Inspection List from inspections of clinical investigators who have conducted studies with investigational new drugs or investigational devices reviewed by CBER

FluLaval Quadrivalent
Thu, 13 Jul 2017 15:12:00 -0400



Seraclone Blood Grouping Reagent Anti-Fya(Monoclonal)
Mon, 10 Jul 2017 12:05:00 -0400



Biologics Guidances
Mon, 03 Jul 2017 12:48:00 -0400



Guidance Agenda: Guidance Documents CBER is Planning to Publish During Calendar Year 2017
Mon, 03 Jul 2017 12:15:00 -0400

Guidance agenda outling guidance documents CBER is planning to publish during calendar year 2017.

Seraclone Blood Grouping Reagent Anti-S (Monoclonal)
Mon, 26 Jun 2017 08:47:00 -0400




Here are some headlines supporting the benefits of a system like ADERS ®:



See how to prevent medication errors with bar codes using ADERS. Get your free pilot started today.




Corporate Headquarters

Practical Compliance Solutions
One Orient Way - Suite F156 Rutherford, NJ 07070
Phone: 201-728-8809


40.827731 N 74.101029 W
Connect With Us


Share




© 2002 - 2017 - Copyright Practical Compliance Solutions - All rights reserved